These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24458537)

  • 1. The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
    Arts EE; Fransen J; den Broeder AA; Popa CD; van Riel PL
    Ann Rheum Dis; 2015 Jun; 74(6):998-1003. PubMed ID: 24458537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study.
    Arts EE; Fransen J; Den Broeder AA; van Riel PLCM; Popa CD
    Ann Rheum Dis; 2017 Oct; 76(10):1693-1699. PubMed ID: 28606965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
    Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
    Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
    Ajeganova S; Andersson ML; Frostegård J; Hafström I
    J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease activity in rheumatoid arthritis and the risk of cardiovascular events.
    Solomon DH; Reed GW; Kremer JM; Curtis JR; Farkouh ME; Harrold LR; Hochberg MC; Tsao P; Greenberg JD
    Arthritis Rheumatol; 2015 Jun; 67(6):1449-55. PubMed ID: 25776112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
    Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.
    Radovits BJ; Fransen J; Al Shamma S; Eijsbouts AM; van Riel PL; Laan RF
    Arthritis Care Res (Hoboken); 2010 Mar; 62(3):362-70. PubMed ID: 20391482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.
    Solomon DH; Greenberg J; Curtis JR; Liu M; Farkouh ME; Tsao P; Kremer JM; Etzel CJ
    Arthritis Rheumatol; 2015 May; 67(8):1995-2003. PubMed ID: 25989470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis.
    Welsing PM; Fransen J; van Riel PL
    Arthritis Rheum; 2005 Sep; 52(9):2616-24. PubMed ID: 16142762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.
    Myasoedova E; Chandran A; Ilhan B; Major BT; Michet CJ; Matteson EL; Crowson CS
    Ann Rheum Dis; 2016 Mar; 75(3):560-5. PubMed ID: 25637001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project.
    Castañeda S; Martín-Martínez MA; González-Juanatey C; Llorca J; García-Yébenes MJ; Pérez-Vicente S; Sánchez-Costa JT; Díaz-Gonzalez F; González-Gay MA;
    Semin Arthritis Rheum; 2015 Jun; 44(6):618-26. PubMed ID: 26058345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms.
    Arts EE; Popa CD; Den Broeder AA; Donders R; Sandoo A; Toms T; Rollefstad S; Ikdahl E; Semb AG; Kitas GD; Van Riel PL; Fransen J
    Ann Rheum Dis; 2016 Apr; 75(4):674-80. PubMed ID: 25691119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease.
    Kapetanovic MC; Lindqvist E; Simonsson M; Geborek P; Saxne T; Eberhardt K
    Scand J Rheumatol; 2010; 39(5):353-9. PubMed ID: 20615160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity.
    da Cunha VR; Brenol CV; Brenol JC; Fuchs SC; Arlindo EM; Melo IM; Machado CA; de Castro Chaves H; Xavier RM
    Scand J Rheumatol; 2012 May; 41(3):186-91. PubMed ID: 22416768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-averaged DAS28 and HAQ predict cardiovascular disease in patients with rheumatoid arthritis: Data from KORONA registry.
    Min HK; Kim HR; Lee SH; Kang KY; Park SH; Kwok SK
    Joint Bone Spine; 2022 Oct; 89(5):105401. PubMed ID: 35513231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
    Ocon AJ; Reed G; Pappas DA; Curtis JR; Kremer JM
    Ann Rheum Dis; 2021 Dec; 80(12):1522-1529. PubMed ID: 34215644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.
    van Halm VP; Nurmohamed MT; Twisk JW; Dijkmans BA; Voskuyl AE
    Arthritis Res Ther; 2006; 8(5):R151. PubMed ID: 16984661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.
    Kaushik P; Solomon DH; Greenberg JD; Anderson JT; Reed G; Pala O; Sumbul-Yuksel B; Kadam P; Kremer JM;
    Clin Rheumatol; 2015 Oct; 34(10):1697-704. PubMed ID: 26242470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
    Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
    J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.